These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Excerpt from the 2022 American Association for the Study of Liver Diseases clinical practice guideline: management of primary sclerosing cholangitis and cholangiocarcinoma]. Yuan J; Han GH Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):35-41. PubMed ID: 36948847 [TBL] [Abstract][Full Text] [Related]
5. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. Claessen MM; Lutgens MW; van Buuren HR; Oldenburg B; Stokkers PC; van der Woude CJ; Hommes DW; de Jong DJ; Dijkstra G; van Bodegraven AA; Siersema PD; Vleggaar FP Inflamm Bowel Dis; 2009 Sep; 15(9):1331-6. PubMed ID: 19229982 [TBL] [Abstract][Full Text] [Related]
6. Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis. Singh S; Edakkanambeth Varayil J; Loftus EV; Talwalkar JA Liver Transpl; 2013 Dec; 19(12):1361-9. PubMed ID: 24019127 [TBL] [Abstract][Full Text] [Related]
7. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175 [TBL] [Abstract][Full Text] [Related]
8. High lifetime risk of cancer in primary sclerosing cholangitis. Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991 [TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898 [TBL] [Abstract][Full Text] [Related]
10. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis. Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555 [TBL] [Abstract][Full Text] [Related]
11. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients? Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867 [TBL] [Abstract][Full Text] [Related]
12. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187 [TBL] [Abstract][Full Text] [Related]
13. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. Saich R; Chapman R World J Gastroenterol; 2008 Jan; 14(3):331-7. PubMed ID: 18200656 [TBL] [Abstract][Full Text] [Related]
14. Immune-mediated diseases in primary sclerosing cholangitis. Lamberts LE; Janse M; Haagsma EB; van den Berg AP; Weersma RK Dig Liver Dis; 2011 Oct; 43(10):802-6. PubMed ID: 21700515 [TBL] [Abstract][Full Text] [Related]
15. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Zhang R; Lauwers GY; Choi WT J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958 [TBL] [Abstract][Full Text] [Related]
16. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228 [TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study. Tan N; Ngu N; Worland T; Lee T; Abrahams T; Pandya K; Freeman E; Hannah N; Gazelakis K; Madden RG; Lynch KD; Valaydon Z; Sood S; Dev A; Bell S; Thompson A; Ding J; Nicoll AJ; Liu K; Gow P; Lubel J; Kemp W; Roberts SK; Majeed A; Hepatol Int; 2022 Oct; 16(5):1094-1104. PubMed ID: 35657479 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis. Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687 [TBL] [Abstract][Full Text] [Related]